Your AI-Powered Market Intelligence

Sunday, August 16, 2026
RSS

IPO

SpaceX's Earnings Debut: A Critical Moment for Investors Following IPO

Investors are eagerly awaiting SpaceX's first earnings report since its IPO, with predictions of potential stock gains on the horizon.

By Theo Marchetti • August 4, 2026
Earnings

Pfizer's Q2 Performance: A Shift Towards Non-Covid Growth

Pfizer exceeds Q2 earnings expectations, signaling a shift to non-Covid revenue streams and raising guidance for the healthcare sector.

Marcus Rivera • Aug 4
Earnings

Palantir's Earnings Surge: What It Means for AI Investments

Palantir's strong Q2 earnings and rising shares suggest a shift in AI adoption dynamics.

Theo Marchetti • Aug 4
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Markets

Prologis and SEGRO: A Landmark $18.8B Mega-Deal in Industrial REITs

Prologis's $18.8B acquisition of SEGRO marks a pivotal moment in the industrial REIT landscape.

James McAllister • Aug 4, 2026
Economy

Atlanta Fed's Q3 GDP Upgrade to 6.2%: What It Means for Investors

The Atlanta Fed's new GDP estimate of 6.2% for Q3 signals potential shifts in economic momentum and interest rate polici…

Marcus Rivera • Aug 3, 2026
Technology

Visa's $2.4B Acquisition of BioCatch: A Strategic Move in Fraud Prevention

Visa's $2.4 billion acquisition of BioCatch enhances its fraud detection capabilities and strengthens its position in th…

Theo Marchetti • Aug 3, 2026
Markets

Curium's $8B Merger with Lantheus: A Major Shift in the Radiopharmaceutical Market

Curium's acquisition of Lantheus for up to $114.50 per share signals a significant shift in the radiopharmaceutical sect…

James McAllister • Aug 3, 2026
Markets

Supernus and Indivior Merger: A Strategic Move in CNS Pharmaceuticals

The merger between Supernus and Indivior promises to reshape the CNS pharmaceutical landscape with significant scale and…

Marcus Rivera • Aug 3, 2026
Markets

Curium's $8B Acquisition of Lantheus: Implications for Investors

Curium's acquisition of Lantheus for up to $114.50 per share marks a significant shift in the radiopharmaceutical landsc…

James McAllister • Aug 3, 2026
Technology

NXP Semiconductors and Ambarella: The Next Big Move in Chip Sector M&A

NXP Semiconductors may acquire Ambarella, signaling a strategic shift in the semiconductor landscape.

Marcus Rivera • Aug 2, 2026
Analysis

KKR's Potential Acquisition of Integer Holdings: What It Means for Investors

KKR's interest in acquiring Integer Holdings at $127 a share raises questions about the healthcare manufacturing sector'…

Theo Marchetti • Aug 2, 2026
Markets

Market Dynamics: S&P 500's Struggle at 7,500 and the Impact of Fed Doubts

The S&P 500's battle at the 7,500 level amid Fed uncertainties highlights critical market dynamics.

James McAllister • Aug 2, 2026